Melanotan Ii vs Tadalafil for libido
Short answer: For libido, more users report improvement with Melanotan Ii — 96% of 48 reports, versus 91% of 99 for Tadalafil.
Melanotan Ii has 1 meta-analyses and 1 randomized trials on PubMed; Tadalafil has 120 and 347.
Based on 186 reports about Melanotan Ii and 253 about Tadalafil. Not medical advice.
| Melanotan Ii Peptide | Tadalafil Medication | |
|---|---|---|
| Users say it helped | 60%helped115 reports · high confidence | 77%helped142 reports · high confidence |
| Verdict | Mixed | Mostly positive |
| Research | BResearch: Moderate | AResearch: Strong |
| Meta-analyses / RCTs | 1 / 1 | 120 / 347 |
| Mainly used for | ||
| Libido % reporting improvement | 96% (48) | 91% (99) |
| Skin & hair % reporting improvement | 88% (84) | — |
| Performance % reporting improvement | 100% (5) | 97% (69) |
| Heart & lipids % reporting improvement | 33% (3) | 95% (22) |
| Mood % reporting improvement | 40% (5) | 100% (10) |
| Common side effects | nausea, flushing, freckles, moles | headache, stuffy nose, heartburn, lower back |
| Typical dose reported | Not listed | Not listed |
Almost all studies are in the preclinical phase. There are currently no effective clinical treatments for MC4R-deficient obese patients, although MC4R agonists are being developed and are entering phase I and II trials.
Int J Obes (Lond), 2014 ↗“I've found that getting sun within 3-12 hours will produce the desired result.”
Tadalafil shares a similar efficacy and safety with sildenafil and significantly improves patients' sexual confidence. Furthermore, patients and their partners prefer tadalafil to sildenafil. Hence, tadalafil may be a better choice for ED treatment.
Int Urol Nephrol, 2017 ↗“After a week of 2.5 mg twice a day, this is my favourite drug ever. My brain fog has gone...My mood is so much better, similar to an SSRI but without the flat feeling.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate